You are here Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 2
Review
Efficacy and tolerability of lumiracoxib, a highly selective cyclo-oxygenase-2 (COX2) inhibitor, in the management of pain and osteoarthritis
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,769 | Dovepress* | 7,769 | 1,721 | 9,490 | |
| Totals | 7,769 | 1,721 | 9,490 | ||
|
*Since 11 April 2008 +Since July 2016 |
|||||
View citations on Google Scholar